Episode Details

Several companies with product candidates in the posterior segment provide updates; Ocuphire acquires an ophthalmic gene therapy company; and Astellas provides an update on its regulatory plans for GA drug avacincaptad pegol.

Learn more about your ad choices. Visit megaphone.fm/adchoices